ArticleOncology letters2026

Optimal timing of stereotactic radiosurgery with first-line osimertinib in EGFR-mutant non-small cell lung cancer brain metastases: Immediate, early-consolidation and salvage strategies.

Xiaona Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.